Pekin Life Insurance Company (PKIN) Stock Price & Analysis
Pekin Life Insurance Company (PKIN) — price $11.75 (0.00%), as of the Nov 19, 2026 trading session; market cap $201M.
Educational signal · not a buy or sell recommendation · How to read this
Pekin Life Insurance Company · PKIN
Pekin Life Insurance Company is a U.S.-based insurer offering a diverse range of life, accident, and health insurance products.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $11.75 | |
| Change on the day | 0.00% | |
| 52-week range | $10.50 – $11.80 | |
| Market capitalisation | $201M | |
| Price / earnings (trailing) | 29.22 | |
| Shares traded on the day | 1.0K |
Price & events
Other perspectives
Council score for Pekin Life Insurance Company (PKIN): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Pekin Life Insurance Company (PKIN), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Pekin Life Insurance Company (PKIN) is the company analyzed here. It employs 156 people and is led by Daniel Vincent Connell. In Q2 FY2026 it reported revenue of $49M and net income of -$629,868. The market values it at $201M.
What do the latest results show for Pekin Life Insurance Company (PKIN)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $49M.
Quarterly income statement — 3 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $49M | -$629,868 | $0.12 (diluted) |
| Q1 FY2026 | $52M | $3M | $0.17 (diluted) |
| Q3 FY2025 | $65M | $1M | $0.09 (diluted) |
What are the financial strengths and risks for Pekin Life Insurance Company (PKIN)?
Short answer · as of
The distress and quality screens read Altman Z 0.11 · Piotroski F 2.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 0.11 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held PKIN in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported PKIN in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: PKIN Stock
These answers are editorial: 1 of these 8 answers is drawn from the PKIN research dossier (written Jun 14, 2026 by gpt-4o-mini); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is PKIN a good stock to buy?
Stock Expert AI does not rate PKIN buy, sell or hold. Pekin Life Insurance Company has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the PKIN stock price today?
The last price recorded for Pekin Life Insurance Company (PKIN), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for PKIN?
Pekin Life Insurance Company faces several risks, including regulatory changes that could impact its operations and profitability. The company also competes with larger insurers, which may affect its market share.
What are the key factors to evaluate for PKIN?
Evaluate PKIN on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Partnerships for Group Benefits: Collaborating with businesses to offer group insurance products can drive growth. Not financial advice.
How frequently does PKIN data refresh on this page?
PKIN's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven PKIN's recent stock price performance?
Pekin Life Insurance Company (PKIN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Long-standing history and experience in the insurance industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PKIN overvalued or undervalued right now?
The trailing P/E of Pekin Life Insurance Company (PKIN) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research PKIN before investing?
Before investing in Pekin Life Insurance Company (PKIN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 9 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com